Kwakernaak R, Brand V, Rojo-Santiago J, Froklage F, Hoogeman M, Habraken S
Phys Imaging Radiat Oncol. 2025; 33:100714.
PMID: 39981525
PMC: 11840216.
DOI: 10.1016/j.phro.2025.100714.
Kusters J, Monshouwer R, Koopmans P, Wendling M, Brunenberg E, Kerkmeijer L
Strahlenther Onkol. 2025; .
PMID: 39808200
DOI: 10.1007/s00066-024-02346-z.
Webster M, Lemus O, Tanny S, Cummings M, Zheng D
Cureus. 2024; 16(9):e68990.
PMID: 39385924
PMC: 11463887.
DOI: 10.7759/cureus.68990.
Onal C, Arslan G, Yavas C, Efe E, Yavas G
Rep Pract Oncol Radiother. 2024; 29(1):10-20.
PMID: 39165591
PMC: 11333072.
DOI: 10.5603/rpor.99358.
Thomas C, Dregely I, Oksuz I, Urbano T, Greener T, King A
BJR Open. 2024; 6(1):tzae014.
PMID: 38948455
PMC: 11213647.
DOI: 10.1093/bjro/tzae014.
A Single-Institution Prospective Study To Evaluate the Safety and Efficacy of Real- Time Image-Gated Spot-Scanning Proton Therapy (RGPT) for Prostate Cancer.
Nishioka K, Hashimoto T, Mori T, Uchinami Y, Kinoshita R, Katoh N
Adv Radiat Oncol. 2024; 9(5):101464.
PMID: 38560429
PMC: 10981019.
DOI: 10.1016/j.adro.2024.101464.
Repeatability and reproducibility of prostate apparent diffusion coefficient values on a 1.5 T magnetic resonance linear accelerator.
Fernando N, Tadic T, Li W, Patel T, Padayachee J, Santiago A
Phys Imaging Radiat Oncol. 2024; 30:100570.
PMID: 38544680
PMC: 10966090.
DOI: 10.1016/j.phro.2024.100570.
MRI-guided radiotherapy in twenty fractions for localised prostate cancer; results from the MOMENTUM study.
Sritharan K, Daamen L, Pathmanathan A, Schytte T, Pos F, Choudhury A
Clin Transl Radiat Oncol. 2024; 46:100742.
PMID: 38440792
PMC: 10909700.
DOI: 10.1016/j.ctro.2024.100742.
Impact of technological advances in treatment planning, image guidance, and treatment delivery on target margin design for prostate cancer radiotherapy: an updated review.
Winter J, Reddy V, Li W, Craig T, Raman S
Br J Radiol. 2024; 97(1153):31-40.
PMID: 38263844
PMC: 11027310.
DOI: 10.1093/bjr/tqad041.
Dynamic intrafractional position monitoring with implanted fiducial markers for enhanced accuracy in radiotherapy of prostate cancer.
Mangesius J, Seppi T, Ibrahim R, Fleischmann K, Ginestet A, Vorbach S
Phys Eng Sci Med. 2023; 46(4):1365-1374.
PMID: 37523057
PMC: 10703977.
DOI: 10.1007/s13246-023-01304-w.
Triggering daily online adaptive radiotherapy in the pelvis: Dosimetric effects and procedural implications of trigger parameter-value selection.
Yock A, Ahmed M, Masick S, Morales-Paliza M, Kluwe C, Shinde A
J Appl Clin Med Phys. 2023; 24(10):e14060.
PMID: 37276079
PMC: 10562041.
DOI: 10.1002/acm2.14060.
Outcome of the first 200 patients with prostate cancer treated with MRI-Linac at Assuta MC.
Gelbart Pridan O, Ben David M, Zalmanov S, Lipski Y, Grinberg V, Levin D
Front Oncol. 2023; 13:1151256.
PMID: 37035136
PMC: 10076851.
DOI: 10.3389/fonc.2023.1151256.
Patient preferences for treatment modalities for localised prostate cancer.
Teunissen F, Hehakaya C, Meijer R, van Melick H, Verkooijen H, van der Voort van Zyp J
BJUI Compass. 2023; 4(2):214-222.
PMID: 36816141
PMC: 9931535.
DOI: 10.1002/bco2.198.
Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac.
Gao L, Tian Y, Wang M, Xia W, Qin S, Song Y
Front Oncol. 2023; 13:1039901.
PMID: 36741014
PMC: 9893501.
DOI: 10.3389/fonc.2023.1039901.
Adaptive dose painting for prostate cancer.
Freden E, Tilly D, Ahnesjo A
Front Oncol. 2022; 12:973067.
PMID: 36237318
PMC: 9552323.
DOI: 10.3389/fonc.2022.973067.
Optimized Adaptive Radiotherapy with Individualized Plan Library for Muscle-Invasive Bladder Cancer Using Internal Target Volume Generation.
Jo Y, Yea J, Park J, Oh S, Won Park J
Cancers (Basel). 2022; 14(19).
PMID: 36230598
PMC: 9564375.
DOI: 10.3390/cancers14194674.
Dosimetric comparison of automatically propagated prostate contours with manually drawn contours in MRI-guided radiotherapy: A step towards a contouring free workflow?.
Sritharan K, Dunlop A, Mohajer J, Adair-Smith G, Barnes H, Brand D
Clin Transl Radiat Oncol. 2022; 37:25-32.
PMID: 36052018
PMC: 9424262.
DOI: 10.1016/j.ctro.2022.08.004.
Technical feasibility of online adaptive stereotactic treatments in the abdomen on a robotic radiosurgery system.
Milder M, Magallon-Baro A, den Toom W, de Klerck E, Luthart L, Nuyttens J
Phys Imaging Radiat Oncol. 2022; 23:103-108.
PMID: 35928600
PMC: 9344339.
DOI: 10.1016/j.phro.2022.07.005.
The first patient-reported outcomes from the Utrecht Prostate Cohort (UPC): the first platform facilitating 'trials within cohorts' (TwiCs) for the evaluation of interventions for prostate cancer.
Teunissen F, Willigenburg T, Meijer R, van Melick H, Verkooijen H, van der Voort van Zyp J
World J Urol. 2022; 40(9):2205-2212.
PMID: 35861861
PMC: 9427931.
DOI: 10.1007/s00345-022-04092-2.
Case Report: MR-Guided Adaptive Radiotherapy, Some Room to Maneuver.
Li W, Winter J, Padayachee J, Dang J, Kong V, Chung P
Front Oncol. 2022; 12:877452.
PMID: 35494044
PMC: 9047540.
DOI: 10.3389/fonc.2022.877452.